ENDPOINTS

Weeks after TIGIT fail, iTeos decides to wind down

Only fifteen days after saying it was searching for strategic alternatives, iTeos Therapeutics' board has determined its answer: It will be shutting down. The move comes quickly after GSK and iTeos ...

May 28, 2025 - 15:44
 0
Weeks after TIGIT fail, iTeos decides to wind down
Only fifteen days after saying it was searching for strategic alternatives, iTeos Therapeutics' board has determined its answer: It will be shutting down. The move comes quickly after GSK and iTeos ...
Read More

Tags:

Previous Article

UK records sunniest spring in over a century

Next Article

How Do We Do Research in Zero Gravity? We Asked a NASA Expert: Episode 62

Related Posts

Eikon Therapeutics cuts staff following $351M Series D

Eikon Therapeutics cuts staff following $351M Series D

May 21, 2025  0

Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision

Biohaven stock sinks on three-month delay for neuro dru...

May 15, 2025  0

Arcturus to prioritize mRNA therapeutics in bid to boost rare disease programs

Arcturus to prioritize mRNA therapeutics in bid to boos...

May 13, 2025  0